| Reduction or total lack of beta-globin chains caused by a congenital disease called ß-thalassemia major is one of the lives threatening diseases. Patients who suffer from ß-thalassemia need a repeated blood transfusion for survival. The repeated blood transfusion in ß-thalassemia patients may cause oxidative stress and tissue injury due to iron overload, altered antioxidant enzymes, and other essential trace element levels. The current study aimed to investigate the correlation of oxidative stress with serum trace element levels and antioxidant enzyme status in ß-thalassemia major patients. A total of 130 serum samples were obtained from ß-thalassemia major patients (n=100; 50 males and 50 females) and healthy individuals (n=30; 15 males and 15 females). Hematological parameters were measured on both groups by a comprehensive blood test that included the amount of hemoglobin Hb, packed cells volume, number of red blood cells, mean corpuscular volume ratio, mean corpuscular hemoglobin ratio, mean corpuscular hemoglobin concentration, red cell distribution width, white blood cells, and platelets counts. All of these blood parameters showed a clear decrease in thalassemia patients, except for red blood cells and platelets counts, which demonstrated a significant increase. The highest significant mean for iron in males and females were 233.768 and 219.150 µgm\dL in patients, respectively, while the mean level of iron significantly reduced in the control group (113.40 and 103.33 µgm\dL in males and females, respectively). The results indicated a significant decrease in uric acid in males and females in the patient group (41.042 and 40.582 mg\L in males and females, respectively), compared to the control group (53.866 and 43.60 mg\L in males and females, respectively). Allantoin concentration was detected by high-performance liquid chromatography technique, the results of which showed that the highest values in patients were 62.822 and 25.480 mg\L in males and females, respectively, compared to the control group 2.342 and 1.481 mg\L in males and females, respectively. Superoxide dismutase concentration decreased in patients (129.635 and 111.848 U\mL in males and females, respectively), compared to the control group (208.623 and 190.413 U\ml in males and females, respectively). |
- Behrman A, Kliegman K, Jenson L. Nelson text book of pediatrics, 19th edn, Saunders. Elsevier; 2011.
- Liao F, Zhao YS, Zhao LN, Tao J, Zhu XY, Liu L. Evaluation of a kinetic uricase method for serum uric acid assay by predicting background absorbance of uricase reaction solution with an integrated method. J Zhejiang Univ Sci B. 2006;7(6):497-502.
- Pizzichini M, Arezzini L, Billarelli C, Carlucci F, Terzuoli L. Determination and Separation of Allantoin, Uric Acid, Hypoxanthine, and Xanthine by Capillary Zone Electrophoresis. In: Griesmacher A, Müller MM, Chiba P, editors. Purine and Pyrimidine Metabolism in Man IX. Boston, MA: Springer US; 1998. p. 797-800.
- Kock R, Delvoux B, Greiling H. A high-performance liquid chromatographic method for the determination of hypoxanthine, xanthine, uric acid and allantoin in serum. Eur J Clin Chem Clin Biochem. 1993;31(5):303-10.
- Bazvand F, Shams S, Esfahani MB, Koochakzadeh L, Monajemzadeh M, Ashtiani M-TH, et al. Total antioxidant status in patients with major β-thalassemia. Iran J Pediatr. 2011;21(2):159.
- Tracz MJ, Alam J, Nath KA. Physiology and pathophysiology of heme: implications for kidney disease. J Am Soc Nephrol. 2007;18(2):414-20.
- Al-Samarrai AH, Adaay MH, Al-Tikriti KA, Al-Anzy MM. Evaluation of some essential element levels in thalassemia major patients in Mosul district, Iraq. Saudi Med J. 2008;29(1):94-7.
- Piga A, Longo F, Duca L, Roggero S, Vinciguerra T, Calabrese R, et al. High nontransferrin bound iron levels and heart disease in thalassemia major. Am J Hematol. 2009;84(1):29-33.
- Kuppusamy U, Tan J. Chelation Therapy with Desferrioxamine does not Normalize Ferritin Level but Attenuates Oxidative Damage and Improves Total Antioxidant Level in Malaysian Chinese β-thalassaemia Major Patients. West Indian Med J. 2011;60(1).
- Abdulla AA. Evaluation of serum antioxidant enzymes in β-thalassemia major patients. Int J Chemtech Res. 2018;11(7):323-8.
- Kassab-Chekir A, Laradi S, Ferchichi S, Khelil AH, Feki M, Amri F, et al. Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia. Clinica Chimica Acta. 2003;338(1-2):79-86.
- Saud AM. Molecular and biochemical study on β-thalassemia patients in Iraq. University of Baghdad; 2012.
- Lamia A. Total Antioxidant Capacity As Indicative of Oxidative Stress on β-Thalassemia Patients. Med J Babylon. 2007;4(3-4).
- Prabhu R, Prabhu V, Prabhu R. Iron overload in beta thalassemia: a review. J Biosci Tech. 2009;1(1):20-31.
- Hamed EA, ElMelegy NT. Renal functions in pediatric patients with beta-thalassemia major: relation to chelation therapy: original prospective study. Ital J Pediatr. 2010;36(1):1-10.
- Al Haddad RM. Molecular, Biochemical and Hematological Investigations of b-Thalassemic Children in Gaza Governorate. 2012.
- Rasool M, Malik A, Jabbar U, Begum I, Qazi MH, Asif M, et al. Effect of iron overload on renal functions and oxidative stress in beta thalassemia patients. Saudi Med J. 2016;37(11):1239.
- Ismaiel MAD. A Novel Keynote in Male Infertility as Oxidative Stress Syndrome: Al-Mustansiriya University; 2001.
- Dhawan V, KhR K, Marwaha R, Ganguly NK. Antioxidant status in children with homozygous thalassemia. Indian Pediatr. 2005;42(11):1141-5.
- Gerli G, Beretta L, Bianchi M, Pellegatta A, Agostoni A. Erythrocyte superoxide dismutase, catalase and glutathione peroxidase activities in β‐thalassaemia (major and minor). Scand J Haematol. 1981;25(1):87-92.
- ŞİMŞEK ORHON F, Öztürk G, KEMAHLI S, Erbaş D, Hasanoğlu A. Oxidant and antioxidant status in beta thalassemia major patients. Ankara Univ Fac Med. 2005;58(1):34-8.
- Patne A, Hisalkar P, Gaikwad S, Patil S. Alterations in antioxidant enzyme status with lipid peroxidation in β thalassemia major patients. Int J Pharm Life Sci. 2012;3(10):2003-6.
- Waseem F, Khemomal KA, Sajid R. Antioxidant status in beta thalassemia major: a single-center study. Indian J Pathol Microbiol. 2011;54(4):761.
- Choudhary M, Vyas RK, Lahoti A. Correlation of oxidative stress with serum antioxidant enzymes level in thalassemia in a tertiary level hospital of western Rajasthan. Int J Biotechnol Biochem. 2017;13(2):155-65.
- Fajans S. Diabetes mellitus, definition, classification, tests. Saunders Co, USA. 1995:1411-22.
- Michiels C, Raes M, Toussaint O, Remacle J. Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. Free Radic Biol Med. 1994;17(3):235-48.
|
